Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANCHIALE: NanoTherm for Recurrent Glioblastoma
NCT06271421Recruiting
- Sponsor
- Poznan University of Medical Sciences
- Start
- Jan 2024
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Poznan University of Medical Sciences. Primary endpoints: Overall Survival at 2 years and Progression-Free Survival at 2 years. Started Jan 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06271421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06271421.